Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in PDSB — PDS Biotechnology Corp

CIK 1423053 MIAMI, FL
Back to PDSB Full portfolio

Position in PDSB

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$285,268
+$285,268 QoQ
Shares Held
323,801
Ownership
0.579%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 52 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PDSB Over Time

Shares Held

Position Value (USD)

Derivatives in PDSB

reported options exposure · as of Jun 30, 2026
CallValue
$21,584
CallShares
24,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. PDSB ranks #297 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in PDSB

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $285,268 323,801
2026-06-30 $21,584 24,500
2026-03-31 $6,836 11,300
2025-09-30 $390,294 386,430
2025-09-30 $28,684 28,400
2025-06-30 $81,130 61,000
2025-06-30 $331,203 249,025
2025-03-31 $80,801 67,900
2025-03-31 $1,428 1,200
2024-12-31 $13,529 8,300
2024-12-31 $358,950 220,215
2024-12-31 $10,921 6,700
2024-09-30 $439,231 114,982
2024-09-30 $23,302 6,100
2024-09-30 $3,438 900
2024-06-30 $14,064 4,800
2024-06-30 $142,720 48,710
2024-06-30 $131,850 45,000
2024-03-31 $43,164 10,900
2024-03-31 $203,405 51,365
2024-03-31 $276,804 69,900
2023-12-31 $647,998 130,382
2023-12-31 $541,730 109,000
2023-12-31 $828,002 166,600
2023-09-30 $543,885 107,700
2023-09-30 $484,744 95,989
2023-09-30 $674,680 133,600
2023-06-30 $643,337 127,900
2023-06-30 $268,602 53,400
2023-06-30 $255,779 50,851
2023-03-31 $1,130,985 183,900
2023-03-31 $131,610 21,400
2023-03-31 $768,177 124,907
2022-12-31 $359,409 27,228
2022-12-31 $5,324,880 403,400
2022-12-31 $636,240 48,200
2022-09-30 $1,056,132 355,600
2022-09-30 $53,163 17,900
2022-09-30 $353,497 119,023
2022-06-30 $326,310 89,400
2022-06-30 $116,496 31,917
2022-06-30 $1,513,655 414,700
2022-03-31 $155,988 25,200
2022-03-31 $540,869 87,378
2022-03-31 $1,517,169 245,100
2021-12-31 $386,370 47,700
2021-12-31 $972,663 120,082
2021-12-31 $266,490 32,900
2021-09-30 $877,610 58,900
2021-09-30 $719,670 48,300